Evaluation of the Presentation of Newly Diagnosed Type 1 Diabetes Mellitus in Children During and After the COVID-19 Pandemic
Öz
Background: The COVID-19 pandemic has been a global health problem with high morbidity and mortality. In this study, it was aimed to compare the clinical and laboratory findings of patients diagnosed with type 1 diabetes(T1D) during the pandemic and after the pandemic.
Method: This is a 30-month, single-center, cross-sectional study. Between October 2020 and December 2021 was defined as the pandemic period, and between January 2022 and March 2023 as the post-pandemic period. The clinical and laboratory parameters of the newly diagnosed T1D patients who applied in these two time periods were compared.
Results: While 87 patients were diagnosed during the pandemic period, 86 patients were diagnosed during the post-pandemic period. The rate of male patients diagnosed during the pandemic period was significantly higher (56%, 36%, respectively, p=0.007). Anti-islet Cell antibody (ICA) positivity was statistically significantly higher in those diagnosed during the pandemic period. (52.6%, 18.6%, respectively, p<0.001). There was no difference between the groups in terms of hemoglobin A1C, thyroid autoantibodies and tissue transglutaminase antibodies (p>0.05).C peptide levels were significantly lower in those diagnosed during the pandemic period (0.39±0.4, 0.63±0.6, respectively, p=0.021). Admissions with severe acidosis were more common during the pandemic than those admitted after the pandemic (29.9%, 16.3%, respectively, p=0.151).
Conclusions: The numbers of children with T1D newly diagnosed in a secondary health center were similar during and after the pandemic. In the pandemic period, admissions with autoantibody positivity, low C-peptide and severe acidosis were more common.
Anahtar Kelimeler
covid 19, diabetes mellitus type 1, newly diagnosed
Etik Beyan
Karar No:2023/01 (18.1.2023 tarihinde) Gaziantep Üniversitesi Tıp Fakültesi Etik kurul biriminden onay alınmıştır.
Kaynakça
- Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020;76:71–6.
- Republic of Turkish Ministry of Health Covid-19 Information page. General Coronavirus Table. Available from: https://covid19.saglik.gov.tr/EN-69532/general-coronavirus-table.html.
- Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care 2020;43:2870–2.
- Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay JA, Brockman N, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes 2021; 22:552–7.
- Orhan Kılıç B, Kılıç S, Gül Ateş E. Vitamin D Status in Turkish Children During the Covid-19 Pandemic; A Single Center Experience. Genel Tıp Derg. 2023;33(4):390-3.
- Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al.ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018;27(19 Suppl):155–77.
- https://data.tuik.gov.tr/Kategori/GetKategori?p=nufus-ve-demografi-109&dil=1
- Republic of Turkey Ministry of Health Covid 19 Vaccination information platform. Available from: https://covid19asi.saglik.gov.tr/?_Dil=2
- Jalilova A, Ata A, Demir G, Işıklar H, Atik Altınok Y, Özen S, Darcan Ş, Gökşen D. The Effect of the SARS-CoV-2 Pandemic on Presentation with Diabetic Ketoacidosis in Children with New Onset Type 1 Diabetes Mellitus. J Clin Res Pediatr Endocrinol. 2023 Aug 23;15(3):264-267.
- Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet 2016;387:2340–8.